Table 1 Baseline patient characteristics and laboratory values
Variable | N (%)/Median (IQR)/Mean (SD) |
|---|---|
Male (%) Female (%) | 74 (54) 63 (46) |
Age (years) | 66 (52–71) |
Haemodialysis (%) | 85 (61.6) |
CKD stage 4–5 (%) | 52 (38.4) |
Haemodialysis vintage (months) | 25 (10.0–53) |
Hypertension (%) | 123 (89) |
Diabetes mellitus (%) | 38 (27.7) |
Smoker (%) | 30 (18.4) |
Chronic ischemic heart disease (%) | 27 (20.1) |
Previous stroke event (%) | 15 (11.3) |
Previous cardiologic event (%) | 35 (26.3) |
Antiplatelet therapy (%) | 48 (35.0) |
Statin therapy (%) | 59 (43.1) |
Vitamin D therapy (%) | 72 (53.3) |
Calcium salt use (%) | 73 (54.1) |
Phosphate binder use (%) | 57 (42.5) |
Cinacalcet treatment (%) | 9 (6.70) |
CACI score (HU) | 137 |
1 (0) | 18 (13.1) |
2 (1–100) | 18 (13.1) |
3 (101–400) | 17 (12.4) |
4 (≥ 400) | 84 (61.3) |
Cholesterol (mg/dl) | 175 (±43.9) |
LDL- cholesterol (mg/dl) | 92.19 (±38.3) |
HDL-cholesterol (mg/dl) | 44.5 (±14.9) |
Triglycerides (mg/dl) | 142 (85–214) |
Uric acid (mg/dl) | 6.99 (± 1.54) |
HbA1c (%) | 6.56 (±1.62) |
Albumin (g/dl) | 4.05 (±0.44) |
eGFR (ml/min/m2) | 11.5 (4.8–22.7) |
Creatinine (mg/dl) | 7.51 (3.52–10.0) |
Urea (mg/dl) | 151 (±48.9) |
Phosphorous (mg/dl) | 4.65 (3.80–5.63) |
Calcium (mg/dl) | 9.38 (±0.72) |
Calcium-phosphorus product | 41.93 (36.1–50.7) |
Bicarbonate (mmol/l) | 19.63 (±4.99) |
Intact PTH (pg/ml) | 220 (94–413) |
TSH (uIU/ml) | 1.28 (0.79–2.78) |
C-reactive protein (mg/l) | 5.9 (3.13–13.1) |